The scale-up, promotion and use of oral pre-exposure prophylaxis (PrEP) in different settings and in different populations.

PrEP programmes and uptake: latest news

PrEP programmes and uptake resources

  • How to get PrEP in the UK

    In England, PrEP is available to people taking part in the PrEP Impact trial.In Wales, Scotland and Northern Ireland, PrEP is available through NHS sexual health clinics.It...

    From: Factsheets

    Information level Level 2

PrEP programmes and uptake news from aidsmap

More news

PrEP programmes and uptake news selected from other sources

  • New Algorithms Could Help Providers ID PrEP Candidates

    Electronic prompts for clinicians to recommend Truvada to people at risk for HIV could help increase PrEP’s impact.

    17 July 2019 | Poz
  • Trial Pairs PrEP With Behavioral Intervention to Prevent HIV in Drug Users

    Yale University investigators are leading a trial that is testing a bio-behavioral intervention’s ability to improve pre-exposure prophylaxis (PrEP) adherence and reduce the risk of HIV acquisition in individuals with opioid dependency, a population experiencing new outbreaks of HIV.

    15 July 2019 | Contagion Live
  • How Australia Could Almost Eradicate H.I.V. Transmissions

    It took universal health care, political will and a health campaign designed to terrify the public, but nearly four decades into the H.I.V. crisis, Australian researchers say the country is on a path toward making transmissions of the virus vanishingly rare.

    12 July 2019 | New York Times
  • PrEP Trials Offer Insight for Reaching at-Risk Women in Sub-Saharan Africa

    Reaching individuals at high risk of acquiring HIV infection continues to pose a challenge to uptake of HIV pre-exposure prophylaxis (PrEP). A new study looked at PrEP clinical trials in sub-Saharan Africa, examining recruitment strategies to reach women at high risk of contracting HIV.

    10 July 2019 | Contagion Live
  • Same-day PrEP initiation a favorable option for patients at risk for HIV

    Same-day initiation of pre-exposure prophylaxis, or PrEP, for HIV prevention was found to be safe, feasible and well-received among patients at a walk-in STD clinic, according to a recently published study. During the study, which was conducted at a clinic in Denver, a high proportion of the participants were linked to ongoing PrEP care, researchers reported.

    10 July 2019 | Healio
  • What Does PrEP Cost Outside the United States?

    For the past several years, doctors in the United States have watched enviously as other countries have approved generic versions of PrEP made by Mylan, Teva, and other generic drug companies. These cheaper generics have made it easier for governments to support large PrEP scale-up programs.

    04 July 2019 | The Body
  • HIV diagnoses in Australia drop to lowest number in 18 years

    Australia continues to lead the world in HIV prevention and in 2018 recorded the lowest number of HIV diagnoses since 2001. According to a report released today by the Kirby Institute at UNSW Sydney, last year there were 835 HIV diagnoses across the country, which represents a decline of 23% over five years.

    03 July 2019 | University of New South Wales
  • Free, fast track access to PrEP now available in London

    Those who meet the eligibility criteria will soon get a free, six month supply of PrEP. The improved access to PrEP comes thanks to HIV and sexual health charity, Terrence Higgins Trust (THT) and the UK’s busiest sexual health clinic, 56 Dean Street.

    01 July 2019 | Gay Star News
  • England: More than a quarter of sexual health clinics closed to new PrEP trial places

    Despite a promised expansion of 13,000 places, Seema Kennedy has revealed that 38 of the 147 sites taking part in the PrEP Impact Trial are closed to some new recruits to the trial.

    01 July 2019 | Pharmaceutical Journal
  • Is the “PrEP4Love” Campaign Reaching African Americans?

    The Chicago-based HIV-prevention effort garnered about 41 million views in its first four months alone. And that’s not all.

    26 June 2019 | Poz
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.